What We're Reading: Page 21
Industry reads hand-picked by our editors
Feb 13, 2025
Feb 12, 2025
-
The Washington Post
How RFK Jr., once a long shot, arrived at the precipice of Trump’s Cabinet
-
FirstWord Pharma
Gilead gets stock bump after Q4 results handily beat expectations
-
Financial Times
Activist fund takes aim at one of Japan’s biggest pharma groups
-
The Guardian
Judge orders CDC and FDA to restore webpages removed after Trump order
Feb 11, 2025
-
Stat
Judge blocks Trump cuts to NIH research payments nationwide
-
Science News
Alzheimer’s scientist resigns after university finds ‘data integrity concerns’ in papers
-
Axios
Health experts sound alarm on weight-loss drugs amid surging demand
-
MedTech Dive
Former FDA head Gottlieb calls for less regulation of certain AI tools
Feb 10, 2025
Feb 07, 2025
-
The Wall Street Journal
White House Preparing Order to Cut Thousands of Federal Health Workers
-
MIT Technology Review
How the tiny microbes in your mouth could be putting your health at risk
-
The New York Times
Abandoned in the Middle of Clinical Trials, Because of a Trump Order
-
The Financial Times
The inside story of Britain’s failure to clinch £450mn AstraZeneca deal
Feb 06, 2025
Feb 05, 2025
-
Axios
Trump tariffs may play havoc with health prices, supply chains
-
The Wall Street Journal
Merck Is Suffering From a Classic Pharma Problem
-
Financial Times
Pfizer CEO ‘disappointed’ by Robert Kennedy’s refusal to rebut claims on vaccine risks
-
AP News
A spine-zapping implant helped 3 people with a muscle-wasting disease walk better
Previous
